Ji Wei-dong, Wu Zhong-liang, Chen Jia-kun, Yi Fei, Feng Su-mei
Institute for Chemical Carcinogenesis, Guangzhou Medical College, Guangzhou 510182, China.
Zhonghua Zhong Liu Za Zhi. 2003 Jan;25(1):26-30.
To detect the alteration of fragile histidine triad (FHIT) gene and p16 gene during malignant transformation of immortal human bronchial epithelial cell line (16HBE) induced by crystalline nickel sulfide, and study the molecular mechanism of nickel carcinogenesis.
Malignant transformed cells and tumorigenic cells were examined for the alteration of FHIT gene and p16 gene by RT-PCR, DNA sequencing and silver staining PCR-SSCP.
Compared with those of control 16HBE, neither mutation of exon2 or exon2-3, abnormal expression in p16 gene nor mutation of FHIT exon5, 6, 7 and 8, exon1-4 or exon5-9 were observed in transformed cells and tumorigenic cells. But aberrant transcript or FHIT gene expression loss were observed in transformed cells and tumorigenic cells. One of the aberrant transcripts in FHIT gene, the deletion of exon6, exon7 and exon8 and an insertion of 36 bp sequence replacing exon6-8, was confirmed by sequencing.
FHIT gene, not p16 gene, could play a definite role in nickel carcinogenesis. Alterations of FHIT gene induced by crystalline NiS could be a molecular event associated with carcinogen, chromosome fragile site instability and cell malignant transformation, and FHIT gene could be one of the important target genes activated by exotic carcinogens.
检测硫化镍晶体诱导人永生化支气管上皮细胞系(16HBE)恶性转化过程中脆性组氨酸三联体(FHIT)基因和p16基因的变化,探讨镍致癌的分子机制。
采用逆转录-聚合酶链反应(RT-PCR)、DNA测序及银染PCR-单链构象多态性(PCR-SSCP)技术检测恶性转化细胞和致瘤细胞中FHIT基因和p16基因的变化。
与对照16HBE细胞相比,转化细胞和致瘤细胞中均未检测到FHIT基因外显子2或外显子2-3的突变、p16基因的异常表达以及FHIT基因外显子5、6、7和8、外显子1-4或外显子5-9的突变。但在转化细胞和致瘤细胞中观察到FHIT基因的异常转录或表达缺失。通过测序证实了FHIT基因的一种异常转录本,即外显子6、外显子7和外显子8缺失,36 bp序列插入取代外显子6-8。
在镍致癌过程中,FHIT基因而非p16基因发挥了一定作用。硫化镍晶体诱导的FHIT基因改变可能是与致癌物、染色体脆性位点不稳定及细胞恶性转化相关的分子事件,FHIT基因可能是外源性致癌物作用的重要靶基因之一。